Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit? - Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC (Internal medicine journal, 2022)